Eastern Bank’s BeOne Medicines Ltd ONC Stock Holding History

Eastern Bank’s Portfolio ONC Stock Details ONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$17.6K	Hold	48	–	–	﹤0.01%	827
2026 Q2	$13.7K	Buy	+48	New	+$14.1K	﹤0.01%	825

Other funds holding ONC

WESPAC Advisors SoCal Pasadena, California $553M AUM 26.96% 1-Year Est. Return

Aaron Wealth Advisors Chicago, Illinois $2.04B AUM 32.69% 1-Year Est. Return

Harbor Investment Advisory Lutherville, Maryland $1.47B AUM 24.2% 1-Year Est. Return

Signature Estate & Investment Advisors Los Angeles, California $5.67B AUM 20.02% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Cape Investment Advisory Mcdonough, Georgia $388M AUM 17.15% 1-Year Est. Return

True Wealth Design Akron, Ohio $426M AUM 16.34% 1-Year Est. Return

Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

Eastern Bank's ONC Position: Q3 2026 in Review

Eastern Bank held its BeOne Medicines Ltd (ONC) position steady in Q3 2026 at 48 shares worth $17.6K. The position accounts for ﹤0.01% of the portfolio, ranked #827.

Eastern Bank first reported a position in ONC in Q2 2026 and has held it in 2 quarters since. 10 funds tracked by Wall St. Rank hold ONC as of Q3 2026.

Eastern Bank held 48 shares of BeOne Medicines Ltd worth $17.6K as of Q3 2026.
Eastern Bank left its BeOne Medicines Ltd share count unchanged in Q3 2026.
BeOne Medicines Ltd made up ﹤0.01% of Eastern Bank's portfolio in Q3 2026, its #827 holding.
Eastern Bank first reported a position in BeOne Medicines Ltd in Q2 2026 and has held it in 2 quarters since.
10 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q3 2026.

Based on Eastern Bank's 13F filing for Q3 2026, filed 5 Oct 2026.